PARNAX LAB
|
The Current P/S Ratio of PARNAX LAB is 0.61.
Share Price | ₹97.4 | May 31,2024 |
Market Cap | ₹112.0 Cr | |
Sales-TTM | ₹183.3 Cr | TTM-Consolidated Results |
Price/Sales | 0.61x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of PARNAX LAB
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹112.0 Cr] as on May 31,2024
(/) Sales [ ₹183.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.61x ]
Thus, for PARNAX LAB , the investors are currently willing to pay '0.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PARNAX LAB !
The chart below summarizes the trend in P/S Ratio of PARNAX LAB over the last five years.
Historical PS (Price/Sales) ratio chart of PARNAX LAB
PS Ratio Performance Analysis for PARNAX LAB
- PARNAX LAB 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.34x.
- PARNAX LAB 's operated at median p/e ratio of 0.26x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PARNAX LAB 's p/e ratio peaked in Mar2022 at 0.79x.
- PARNAX LAB 's p/e ratio hit its five-year low in Mar2020 of 0.11x.
How does PARNAX LAB 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
PARNAX LAB | 183.3 | 0.61 | 112.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 48,496.9 | 7.22 | 350,339.0 |
CIPLA LTD | 25,774.1 | 4.54 | 116,930.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.45 | 96,546.9 |
ZYDUS LIFESCIENCES LTD | 19,547.4 | 5.15 | 100,694.0 |
DIVIS LABORATORIES LTD | 7,845.0 | 14.58 | 114,416.0 |
MANKIND PHARMA LTD | 10,334.8 | 8.32 | 85,978.3 |
TORRENT PHARMACEUTICALS LTD | 10,728.0 | 8.51 | 91,258.4 |
LUPIN LTD | 20,010.8 | 3.62 | 72,388.0 |
AUROBINDO PHARMA LTD | 29,001.9 | 2.40 | 69,550.9 |
ABBOTT INDIA LTD | 5,848.9 | 9.40 | 54,984.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PARNAX LAB 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 0.61x |
Max industry PS | 14.58x |
Median industry PS | 5.15x |
Average industry PS | 6.16x |
You may also like the below Video Courses